Chapter 1 Introduction
1.1 Executive Summary
1.2 Market Definition
1.3 Scope of the Study
Chapter 2 Research Methodology
2.1 Secondary Research
2.2 Primary Research
2.3 Analytic Tools and Model
2.4 Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5 Expert Validation
2.6 Study Timeline
Chapter 3 Market Analysis
3.1 Industry Value Chain Analysis
3.2 Porter's Five Force Analysis
3.2.1 Bargaining Power of Buyers
3.2.2 Bargaining Power of Suppliers
3.2.3 Threats of Substitutes
3.2.4 Threats of New Entrants
3.2.5 Industry Rivalry
3.3 PESTLE Analysis
3.3.1 Political
3.3.2 Economical
3.3.3 Social
3.3.4 Technological
3.3.5 Legal
3.3.6 Environmental
3.4 SWOT Analysis
3.4.1 Strengths
3.4.2 Weakness
3.4.3 Opportunities
3.4.4 Threats
3.5 Y-O-Y Analyses
Chapter 4 Market Dynamics
4.1. Drivers
4.1.1 Increase Prevalence of Diseases
4.1.2 Rising Demand for Blood Component
4.1.3 Increase in number of Complex Surgical Procedures
4.2 Restraints
4.2.1 Lack of awareness about Apheresis System
4.3 Opportunities
4.3.1 Increase in Government Funds
4.3.2 Increase in economies from emerging countries.
4.4 Challenges
4.4.1 High Cost of Apheresis System Equipment
Chapter 5 Europe Apheresis Market– By Procedures
5.1 Automated/Apheresis Blood Collection
5.2 Therapeutic Apheresis
5.2.1 Therapeutic Apheresis by Diseases
5.2.1.1 Neurological Disorders
5.2.1.2 Blood Disorders
5.2.1.3 Renal Disorders
5.2.1.4 Autoimmune Disorders
5.2.1.5 Others
5.2.2 Therapeutics Apheresis by Procedures
5.2.2.1 Photopheresis
5.2.2.2 Extracorporeal Immunoadsorption
5.2.2.3 Therapeutic Cytapheresis
5.2.2.4 Others
Chapter 6 Europe Apheresis Market– By Product
6.1 Apheresis Devices
6.1.1 Plasma Separators
6.1.2 Hemoperfusion Columns
6.1.3 Plasma Component Separators
6.1.4 Immunoadsorption Columns
6.1.5 Plasma Perfusion Columns
6.2 Apheresis Disposables
Chapter 7 Europe Apheresis Market- By Technology
7.1 Centrifugation
7.1.1 Intermittent Flow
7.1.2 Continuous Flow
7.2 Membrane Separation
Chapter 8 Europe Apheresis Market- By Applications
8.1 Plasmapheresis
8.2 Plateletpheresis
8.3 Erythocytapheresis
8.4 Leukapheresis
8.5 Others
Chapter 9 Europe Apheresis Market- By End - User
9.1 Hospitals
9.2 Blood Collection Centers
9.3 Research Institutes
9.4 Others
Chapter 10 Europe Apheresis Market- By Geography
10.1 Introduction
10.2 Europe
10.2.1 U.K.
10.2.2 Germany
10.2.3 France
10.2.4 Italy
10.2.5 Spain
10.2.6. Others
Chapter 11 Europe Apheresis Market- Company Profiles
11.1 Fresenius SE & Co. KGaA
11.2 Cerus Corporation
11.3 Asahi Kasei Medical Co., Ltd.
11.4 Haemonetics Corporation
11.5 Kaneka Corporation
11.6 Kawasumi Laboratories Inc.
11.7 Nikkiso Co., Ltd.
11.8 Terumo BCT, Inc.
11.9 Hemacare Corporation
11.10 B. Braun Melsungen AG
Chapter 12 Europe Apheresis Market- Competitive Landscape
12.1. Market Share Analysis
12.2. Strategies Adopted by top companies
12.3. Mergers, Acquisitions, Collaborations & Agreements
Chapter 13 Market Insights
13.1. Industry Experts Insights
13.2. Analysts Opinions
13.3. Investment Opportunities
Chapter 14 Appendix
14.1 List of Tables
14.2 List of Figures
